Pinnacle Biologics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pinnacle Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013947
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia Healthcare Corp. is a drug company that develops and markets photodynamic therapy products. The company offers products such as PHOTOFRIN PI, OPTIGUIDE PI, ETHYOL PI and DIOMED products. Its OPTIGUIDE PI products comprise light delivery system, coated silica laser fiber, proximal SMA-type laser connector, and distal light diffusing tips. The company offers its vital medicines used to treat various cancers and rare diseases. It sells products through a network of distributors in the US and abroad. Pinnacle Biologics is headquartered in Chicago, Illinois, the US.

Pinnacle Biologics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pinnacle Biologics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Pinnacle Biologics Acquires PHOTOFRIN And PHOTOBARR From Axcan Pharma 11
Venture Financing 13
Pinnacle Biologics Raises Funds Through Venture Financing 13
Pinnacle Biologics Secures US$1.5 Million In Venture Financing 14
Partnerships 15
Pinnacle Biologics Enters into Distribution Agreement with Orphan Canada for Photofrin 15
Pinnacle Biologics Enters Into Co-Marketing Agreement With Alkopharma 16
Licensing Agreements 17
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 17
Acquisition 18
Concordia Healthcare Acquires Pinnacle Biologics 18
Pinnacle Biologics Inc – Key Competitors 20
Pinnacle Biologics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pinnacle Biologics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pinnacle Biologics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pinnacle Biologics Acquires PHOTOFRIN And PHOTOBARR From Axcan Pharma 11
Pinnacle Biologics Raises Funds Through Venture Financing 13
Pinnacle Biologics Secures US$1.5 Million In Venture Financing 14
Pinnacle Biologics Enters into Distribution Agreement with Orphan Canada for Photofrin 15
Pinnacle Biologics Enters Into Co-Marketing Agreement With Alkopharma 16
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 17
Concordia Healthcare Acquires Pinnacle Biologics 18
Pinnacle Biologics Inc, Key Competitors 20
Pinnacle Biologics Inc, Subsidiaries 21

★海外企業調査レポート[Pinnacle Biologics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GCL-Poly Energy Holdings Ltd:企業の発電所・SWOT分析2018
    GCL-Poly Energy Holdings Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Korea Aerospace Industries Ltd.:企業の戦略・SWOT・財務情報
    Korea Aerospace Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Korea Aerospace Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cytori Therapeutics Inc (CYTX)-医療機器分野:企業M&A・提携分析
    Summary Cytori Therapeutics Inc (Cytori) is a clinical stage regenerative medicine company. It develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease, orthopedic conditions and gastrointestinal disorders. The company has two …
  • Sunesis Pharmaceuticals Inc (VIRX):企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Altona Energy Plc:企業の戦略・SWOT・財務情報
    Altona Energy Plc - Strategy, SWOT and Corporate Finance Report Summary Altona Energy Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Azimut Exploration Inc (AZM):企業の財務・戦略的SWOT分析
    Summary Azimut Exploration Inc (AEI) is a mining company that offers exploration and development of mineral resources. The company carries out the business of acquisition, exploration, and development of gold, copper, silver, chromium, uranium and rare earth element properties. It also offers projec …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Acme United Corporation:企業の戦略・SWOT・財務情報
    Acme United Corporation - Strategy, SWOT and Corporate Finance Report Summary Acme United Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • InSightec Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its servi …
  • Pegasystems Inc (PEGA):企業の財務・戦略的SWOT分析
    Pegasystems Inc (PEGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Zest Dental Solutions:医療機器:M&Aディール及び事業提携情報
    Summary Zest Dental Solutions (Zest Dental), formerly ZEST Anchors LLC is a medical device manufacturing company that manufactures, develops, and distributes dental solutions for the treatment of edentulous patients. The company’s products include dental removal tool, attachment processing materials …
  • Symphony Ltd:企業の戦略・SWOT・財務分析
    Symphony Ltd - Strategy, SWOT and Corporate Finance Report Summary Symphony Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Terna SpA (TRN):電力:M&Aディール及び事業提携情報
    Summary Terna SpA (Terna) is an electricity transmission system operator (TSO). It operates high-voltage grid and carries out transmission and dispatching of electricity, maintains transmission infrastructure, plans and constructs the grid, and undertakes grid development projects. It offers special …
  • Beacon Industries Inc.:企業の戦略・SWOT・財務情報
    Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PT Bank Bukopin Tbk:企業の戦略・SWOT・財務分析
    PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Coherent Inc (COHR):企業の財務・戦略的SWOT分析
    Coherent Inc (COHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Capstone Therapeutics Corp (CAPS):企業の財務・戦略的SWOT分析
    Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp, is a biotechnology company that develops and sells novel peptides and other molecules for helping patients with under-served medical conditions. The company develops Apo E mimetic peptide molecule AEM-28 and its analogs that ha …
  • Medigen Biotechnology Corp (3176):企業の財務・戦略的SWOT分析
    Medigen Biotechnology Corp (3176) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Europa Oil & Gas (Holdings) plc (EOG):企業の財務・戦略的SWOT分析
    Summary Europa Oil & Gas (Holdings) Plc (Europa Oil) is an oil and gas company that offers exploration and development services. The company's services include production and development of conventional and unconventional hydrocarbon assets. It operates its assets in East Midlands basin, Aquitain ba …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆